InMed Pharmaceuticals annual capital expenditures (capex)
2020
2021
2022
2023
2024
InMed Pharmaceuticals Capital Expenditures (CapEx) Growth & History (INM)
InMed Pharmaceuticals's capital expenditures (capex) was $9,293 for fiscal 2024.
View full InMed Pharmaceuticals company overviewInMed Pharmaceuticals annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-06-30 | $9,293 | −$150,721 | −94.19% |
| 2023 | 2023-06-30 | $160,014 | $120,906 | +309.16% |
| 2022 | 2022-06-30 | $39,108 | $37,383 | +2167.13% |
| 2021 | 2021-06-30 | $1,725 | −$40,848 | −95.95% |
| 2020 | 2020-06-30 | $42,573 | — | — |
InMed Pharmaceuticals quarterly capital expenditures (capex)
Q1.20
Q2.20
Q3.20
Q4.20
Q1.22
Q2.22
Q3.22
Q4.22
Q3.24
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-03-31 | $2 | — | — |
| Q4 2022 | 2022-06-30 | $0 | — | — |
| Q3 2022 | 2022-03-31 | $3,553 | — | — |
| Q2 2022 | 2021-12-31 | $214,445 | — | — |
| Q1 2022 | 2021-09-30 | $250,000 | — | — |
| Q4 2020 | 2020-06-30 | $923 | — | — |
| Q3 2020 | 2020-03-31 | $8,795 | — | — |
| Q2 2020 | 2019-12-31 | $2,171 | — | — |
| Q1 2020 | 2019-09-30 | $32,530 | — | — |
InMed Pharmaceuticals capital expenditures (capex) trends
Between the periods ended 2020-06-30 and 2024-06-30, InMed Pharmaceuticals's capital expenditures (capex) decreased from $42,573 to $9,293, a change of −$33,280. The latest reported quarter, Q3 2024, shows $2.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review InMed Pharmaceuticals source filings ↗